Stock VTVT VTV THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News vTv Therapeutics Inc.

Equities

VTVT

US9183852048

Delayed Nasdaq
Other stock markets
 12:28:53 2024-04-19 pm EDT 		5-day change 1st Jan Change
24.21 USD -2.14% Intraday chart for vTv Therapeutics Inc. -1.29% +110.52%
Mar. 14 VTv Therapeutics Inc. Announces Board Changes CI
Mar. 13 VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT
PR
VTv Therapeutics Inc. Announces Board Changes
CI
VTv Therapeutics: Q4 Earnings Snapshot
AQ
VTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
AQ
VTv Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
VTv Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
VTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
AQ
VTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
AQ
VTv Therapeutics Inc. Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes
CI
VTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
AQ
Top Midday Gainers
MT
VTv Therapeutics Inc. Announces Board Changes
CI
VTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund
AQ
VTv Therapeutics Inc. announced that it has received $50.961457 million in funding from JDRF T1D Fund, Samsara BioCapital LLC and another investors
CI
CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE
PR
Vtv Therapeutics Inc. Announces Resignation of Chandresh Harjivan as Member of the Board of Directors
CI
VTv Therapeutics: Q3 Earnings Snapshot
AQ
VTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update
AQ
VTv Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
VTv Therapeutics to Participate at the Stifel 2023 Healthcare Conference
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VTVT Stock
  4. News vTv Therapeutics Inc.